AOP Orphan Wants Remnants Of €142M Award OK'd In Mass.
By Nadia Dreid · March 11, 2022, 9:27 PM EST
Although a German court ruled to set aside a €142 million ($161.8 million) arbitral award issued to Austrian pharmaceutical company AOP Orphan last month, the Austrian company and the Taiwanese drug...
To view the full article, register now.